It is mainly divided into four subtypes: Luminal A, Luminal B, epidermal growth factor receptor (HER)2+ and triple negative breast cancer (TNBC) by the biomarkers estrogen receptor (ER), progesterone receptor (PR) and HER2. Here, ESR1 is linked to triple-negative breast carcinoma.